Table 1.

Inhibition of HCV and SARS-CoV-2 replication by selected drugs

(nM)	HCV				SARS-CoV-2
	Infection		Replicon RNA transfection
	EC50	CC50	EC50	CC50	EC50	CC50
Daclatasvir	<0.006	>25	<0.006	>25	–	–
PI4KA-G1	23.8	>4,000	19.8	>4,000	–	–
PIK-III	318.2	>4,000	309.5	>4,000	172.5	∼50,000
Remdesivir	–	–	–	–	79.2	>10,000

EC₅₀ and CC₅₀ values were calculated using datasets reported in Figures 2A, 2D, and S2C.